Skip to main content
OpenTrials

Clinical trial condition

Non-Muscle Invasive Bladder Neoplasms

Explore clinical trials studying Non-Muscle Invasive Bladder Neoplasms. Study availability and eligibility vary by location and protocol.

195 public trials 69 recruiting studies
Refine in advanced search Browse all conditions

Non-Muscle Invasive Bladder Neoplasms trial results

Recruiting

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

NCT05951179

Conditions
Carcinoma, Carcinoma in Situ, Female Urogenital Diseases, +14 more
Locations
  • Urology Centers of Alabama Homewood, Alabama, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • East Valley Urology Center of Arizona Queen Creek, Arizona, United States
  • Arkansas Urology Little Rock, Arkansas, United States
View all 71 locations
View Trial Details
Recruiting

Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer

NCT07673016

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +21 more
Locations
  • Urology San Diego Oceanside, California, United States
  • Genesis Research, LLC San Diego, California, United States
  • Urology Associates of Silicon Valley San Jose, California, United States
  • UroPartners, LLC Chicago, Illinois, United States
View all 23 locations
View Trial Details
Recruiting

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

NCT07480356

Conditions
Bladder (Urothelial, Transitional Cell) Cancer, Carcinoma, Carcinoma in Situ, +16 more
Locations
  • East Valley Urology Center of Arizona Queen Creek, Arizona, United States
  • Arkansas Urology Little Rock, Arkansas, United States
  • Michael Oefelein Clinical Trials Bakersfield, California, United States
  • Renown Regional Medical Center St Louis, Missouri, United States
View Trial Details
Recruiting

Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2

NCT07225127

Conditions
Bladder Cancer, Carcinoma, Female Urogenital Diseases, +15 more
Locations
  • H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • University of Iowa Iowa City, Iowa, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • The Ohio State University Columbus, Ohio, United States
View Trial Details
Recruiting

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

NCT04752722

Conditions
Carcinoma, Carcinoma in Situ, Female Urogenital Diseases, +15 more
Locations
  • The University of Alabama at Birmingham Clinical Research Unit (CRU) Birmingham, Alabama, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • Urological Associates of South Arizona Tucson, Arizona, United States
  • Arkansas Urology Little Rock, Arkansas, United States
View all 102 locations
View Trial Details
Recruiting

Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy

NCT07144319

Conditions
Bladder Cancer, Carcinoma, Female Urogenital Diseases, +14 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Regents of the University of Michigan Ann Arbor, Michigan, United States
  • Rutgers Cancer Institute New Brunswick, New Jersey, United States
  • Oslo University Hospital Oslo, Norway
View Trial Details
Recruiting

DURvalumab in Combination With S-488210/S-488211 vAccine in Non-muscle Invasive Bladder CancEr

NCT04106115

Conditions
Bladder Cancer, Carcinoma, Female Urogenital Diseases, +13 more
Locations
  • Cambridge University NHS FT Cambridge, United Kingdom
  • Guy's and St Thomas' NHS Foundation Trust London, United Kingdom
  • Royal Free London NHS FT London, United Kingdom
  • The Royal Marsden NHS Foundation Trust London, United Kingdom
View Trial Details
Recruiting

Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer

NCT05316155

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
Locations
  • University of Alabama at Birmingham - The Kirklin Clinic Birmingham, Alabama, United States
  • University of Southern California Los Angeles, California, United States
  • Urology Associates of Denver Lone Tree, Colorado, United States
  • Urological Research Network Hialeah, Florida, United States
View all 59 locations
View Trial Details

Related conditions